Chronic Oxidative Stress Increases Resistance to Doxorubicin-Induced Cytotoxicity in Renal Carcinoma Cells Potentially Through Epigenetic Mechanism

Abstract

Renal cell carcinoma is the most common form of kidney cancer and is highly resistant to chemotherapy. Although the role of oxidative stress in kidney cancer is known, the chemotherapeutic response of cancer cells adapted to chronic oxidative stress is not clear. Hence, the effect of oxidative stress on sensitivity to doxorubicin-induced cytotoxicity was evaluated using an in vitro model of human kidney cancer cells adapted to chronic oxidative stress. Results of MTT-and anchorage-independent growth assays and cell cycle analysis revealed significant decrease in sensitivity to doxorubicin in Caki-1 cells adapted to oxidative stress. Changes in the expression of genes involved in drug transport, cell survival, and DNA repair-dependent apoptosis further confirmed increased resistance to doxorubicin-induced cytotoxicity in these cells. Decreased expression of mismatch repair (MMR) gene MSH2 in cells exposed to oxidative stress suggests that loss of MMR-dependent apoptosis could be a potential mechanism for increased resistance to doxorubicin-induced cytotoxicity. Additionally, downregulation of HDAC1, an increase in the level of histone H3 acetylation, and hypermethylation of MSH2 promoter were also observed in Caki-1 cells adapted to chronic oxidative stress. DNA-demethylating agent 5-Aza-2dC significantly restored the expression of MSH2 and doxorubicin-induced cytotoxicity in Caki-1 cells adapted to chronic oxidative stress, suggesting the role of DNA hypermethylation in inactivation of MSH2 expression and consequently MMRdependent apoptosis in these cells. In summary, this study for the first time provides direct evidence for the role of oxidative stress in chemotherapeutic resistance in renal carcinoma cells potentially through epigenetic mechanism.

Low-Dose Ionizing Radiation Exposure, Oxidative Stress and Epigenetic Programing of Health and Disease

“…An example of oxidative stress-mediated hypermethylation due to histone modifications is evident in the DMA-mismatch repair gene (MSH2) promoter. Chronic oxidative stress resulted in enhanced histone H3K27 acetylation, reduced HDAC1 expression, and hypermethylation of the DNA-mismatch repair (MMR) transcription (116). This epigenetic hypermethylation of the MSH2 promoter resulted in loss of MMR-mediated cell apoptosis.…”

Migration and Proliferation Effects of Thymoquinone-Loaded Nanostructured Lipid Carrier (TQ-NLC) and Thymoquinone (TQ) on In Vitro Wound Healing Models

“…ey usually have failed to progress through the normal stages of healing [6] and get trapped in a permanent inflammatory stage due to an imperfect or uncoordinated healing process [7][8][9]. Wound healing is the body's natural reaction that leads to repair of the injured tissue [10] and is not seen as a problem in normal healthy individuals [11]. Many of the repair processes are common to all tissues and take place starting at the cellular stage.…”

Evaluation of the use of therapeutic peptides for cancer treatment

“…Doxorubicin is a conventional chemotherapeutic agent that is widely used in the treatment of many tumours. However, it causes oxidative stress-mediated injury to the kidney [10], heart [11], and brain [12]. Metastatic breast cancer resistance to chemotherapeutic agents remain an obstacle for effective treatment.…”